Filing Details
- Accession Number:
- 0001127602-20-026757
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-09 17:12:45
- Reporting Period:
- 2020-10-08
- Accepted Time:
- 2020-10-09 17:12:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1559405 | E Bradley Lerman | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Svp General Counsel & Corp Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2020-10-08 | 19,917 | $62.76 | 74,242 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2020-10-08 | 19,917 | $110.00 | 54,325 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2020-10-08 | 797 | $62.76 | 55,122 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2020-10-08 | 797 | $110.00 | 54,325 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2020-10-08 | 19,917 | $0.00 | 19,917 | $62.76 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2020-10-08 | 797 | $0.00 | 797 | $62.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
19,918 | 2024-07-28 | No | 4 | M | Direct | |
797 | 2024-07-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- This option to purchase 39,835 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 39,835 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- This option become exercisable on June 29, 2018, subject to New Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018."